Hypercalcaemia -Remove source of calcium. Rehydration may be necessary (if necessary with intravenous 0.9% sodium chloride) and a loop diuretic may be given to increase urinary calcium excretion.
3 years.
None known.
All Flavour Tablets
Microcrystalline Cellulose
Maize Starch
Dextrose Monohydrate
Sodium Saccharin
Magnesium Stearate
Blackcurrant Flavour Tablets
Patent Blue V Lake E131
Ponceau 4R Lake E124
Blackcurrant Flavour 9/696044
Cherry Flavour Tablets
Ponceau 4R Lake E124
Cherry Flavour 630277F
Lemon Flavour Tablets
Quinoline Yellow Lake E104
Lemon Flavour 610364E
Orange Flavour Tablets
Sunset Yellow Lake E110
Orange Flavour 655280 SD
Calcium Carbonate can cause constipation and flatulence. Hypercalcaemia can occur as can alkalosis following the regular use of Calcium Carbonate. The milk-alkali syndrome has occasionally occurred in patients taking large doses. 'Acid Rebound' has been reported on cessation of Calcium Carbonate.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.
Not applicable.
Antacid.
Mechanism of Action/Effect
Calcium Carbonate reacts chemically to neutralise or buffer existing quantities of stomach acid but has no direct effect on its output. This action results in increased pH value of stomach contents, thus providing relief of hyperacidity symptoms. It also reduces acid concentration within the lumen of the oesophagus, thus causing an increase in intra-oesophageal pH and a decrease in pepsin activity, which aids the control of gastro-oesophageal reflux.
ATC code: A02AC01.
Not applicable.
03/01/2018
Wrafton Laboratories Limited Wrafton Braunton North Devon EX33 2DL
Do not store above 25°C.
250 micron clear white UPVC/20 micron hard temper, heat seal coated aluminium foil. 24, 48, 72, 96 tablets/carton.
Polypropylene bottle with polyethylene tamper evident caps 72, 75, 95, 100 tablets/bottle.
Roll wrap of 20 tablets in 9 micron soft aluminium foil/6 gsm wax/20 gsm paper. 40, 60, 80, 100, 120 packs will be 2, 3, 4, 5, 6 rolls in a carton.
Roll wrap of 12 tablets in 9 micron soft aluminium foil/6 gsm wax/20 gsm paper. 24, 36, 48, 60, 72, 96 packs will be 2, 3, 4, 5, 6, 8 rolls in a carton.
PL 12063/0013.
If symptoms persist consult your doctor. Keep all medicines out of the sight and reach of children.
The leaflet shall say:
Each tablet contains 523 mg of glucose (dextrose) per tablet. This should be taken into account in patients with diabetes mellitus.
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.
None known.
None.
ADMINISTRATION DETAILS
28 July1993
